NRX Pharmaceuticals, Inc. has filed 464 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-22 | Other Events |
| 8-K | 2026-06-04 | Entry into a Material Definitive Agreement; Other Events |
| 424B5 | 2026-06-03 | 424B5 |
| 424B5 | 2026-06-02 | 424B5 |
| 8-K | 2026-06-02 | Other Events; Financial Statements and Exhibits |
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |
| 10-Q | 2026-05-15 | Quarterly Report |
| 8-K | 2026-03-24 | Departure/Appointment of Directors or Officers; Submission of Matters to a Vote of Security Holders |
| 10-K | 2026-03-23 | Annual Report |
| DEFA14A | 2026-02-24 | Additional Proxy Soliciting Materials |